preclinical oncology services, biotech, oncology
Drug Development Services
Exiris offers an integrated preclinical platform to accelerate translational research in oncology that is composed of:
A large collection of primary human cancer-stem cell based in vitro and in vivo models that recapitulate human tumor histology and cell hierarchies.
Innovative biomarker identification and validation technologies with expert bioinformatic support
Development of in vitro and in vivo assays and screening campaigns
Xenografts and transgenic in vivo cancer models
Opportunity to involve top experts in preclinical and clinical oncology in all aspects of the project to ensure a seamless translation of preclinical results into clinical trial design
Exiris is also using its internal and external capabilities to develop new targeted agents up to clinical proof of concept.
Copyright © Exiris - P.IVA 10897561006 -Tutti i diritti riservati
Creazione siti internet
By continuing browsing you agree to receive cookies from this site.